Form 4 for MRNA Moderna
Accepted 2022-06-10 00:00:00 ET · period of report 2022-06-08 · accession 0001127602-22-017229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-06-10 | 2022-06-08 | MRNA | Andres Juan | See remarks | M - OptEx | $20.51 | +10.0K | 13.7K | +268% | +$205.1K |
| D | 2022-06-10 | 2022-06-08 | MRNA | Andres Juan | See remarks | S - Sale+OE | $150.00 | -10.0K | 10.4K | -49% | -$1.50M |
| DM | 2022-06-10 | 2022-06-08 | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-08 | M | A | 2,000 | $20.93 | 19,738 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-08 | S | D | 10,000 | $150.00 | 10,367 | D | — | — | |
| 3 | Common | Common Stock | 2022-06-08 | M | A | 629 | $14.22 | 20,367 | D | — | — | |
| 4 | Common | Common Stock | 2022-06-08 | M | A | 2,000 | $20.93 | 17,738 | D | — | — | |
| 5 | Common | Common Stock | 2022-06-08 | M | A | 2,000 | $20.93 | 15,738 | D | — | — | |
| 6 | Common | Common Stock | 2022-06-08 | M | A | 1,371 | $20.93 | 11,738 | D | — | — | |
| 7 | Common | Common Stock | 2022-06-08 | M | A | 2,000 | $20.93 | 13,738 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-06-08 | M | D | 1,371 | $0.00 | 253,025 | D | $20.93 · — to 2029-03-08 | 1,371 Common Stock | (F2) 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 9 | Derivative | Stock Option (Right to Buy) | 2022-06-08 | M | D | 2,000 | $0.00 | 245,025 | D | $20.93 · — to 2029-03-08 | 2,000 Common Stock | (F2) 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 10 | Derivative | Stock Option (Right to Buy) | 2022-06-08 | M | D | 2,000 | $0.00 | 247,025 | D | $20.93 · — to 2029-03-08 | 2,000 Common Stock | (F2) 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 11 | Derivative | Stock Option (Right to Buy) | 2022-06-08 | M | D | 2,000 | $0.00 | 249,025 | D | $20.93 · — to 2029-03-08 | 2,000 Common Stock | (F2) 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 12 | Derivative | Stock Option (Right to Buy) | 2022-06-08 | M | D | 2,000 | $0.00 | 251,025 | D | $20.93 · — to 2029-03-08 | 2,000 Common Stock | (F2) 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 13 | Derivative | Stock Option (Right to Buy) | 2022-06-08 | M | D | 629 | $0.00 | 0 | D | $14.22 · — to 2028-02-28 | 629 Common Stock | (F3) This option is fully vested and exercisable. |